From BioLtd Balance Sheet Health
Financial Health criteria checks 3/6
From BioLtd has a total shareholder equity of ₩65.7B and total debt of ₩22.9B, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are ₩93.5B and ₩27.7B respectively.
Key information
34.8%
Debt to equity ratio
₩22.90b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩8.70b |
| Equity | ₩65.71b |
| Total liabilities | ₩27.74b |
| Total assets | ₩93.45b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A377220's short term assets (₩37.3B) exceed its short term liabilities (₩22.7B).
Long Term Liabilities: A377220's short term assets (₩37.3B) exceed its long term liabilities (₩5.0B).
Debt to Equity History and Analysis
Debt Level: A377220's net debt to equity ratio (21.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if A377220's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A377220 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A377220 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34% each year